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Background
It has been suggested that people with intellectual disabilities
have a higher likelihood to develop psychiatric disorders, and
that their treatment prognosis is relatively poor.
Aims
We aimed to establish the prevalence of intellectual disability in
different mental healthcare settings, and estimate percentage of
cognitive decline. We hypothesised that the prevalence of
intellectual disabilities increases with intensity of care.
Method
A cross-sectional study was conducted in different settings in a
mental healthcare trust in the Netherlands. We used the
Screener for Intelligence and Learning Disabilities (SCIL) to iden-
tify suspected mild intellectual disability (MID) or borderline
intellectual functioning (BIF). We identified patients with a high
level of education and low SCIL score to estimate which patients
may have had cognitive decline.
Results
We included 1213 consecutive patients. Over all settings, 41.4%
of participating patients were positive for MID/BIF and 20.2%
were positive for MID only. Prevalence of suspected MID/BIF
increased by setting, from 27.1% in out-patient settings to 41.9%
in flexible assertive community treatment teams and admission
wards, to 66.9% in long-stay wards. Only 85 (7.1%) of all patients
were identified as possibly having cognitive decline. Of these,
25.9% were in long-stay wards and had a diagnosis of schizo-
phrenia or substance use disorder.
Conclusions
Low intellectual functioning is common in Dutch mental health-
care settings. Only a modest number of patients were identified
as suffering from cognitive decline rather than suspected MID/
BIF from birth. Therefore, we recommend improved screening of
psychiatric patients for intellectual functioning at the start of
treatment.
Keywords
Intellectual disability; community mental health teams; out-
patient treatment; SCIL; in-patient treatment.
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Prevalence of intellectual disabilty inmental health care
In the Netherlands, as in many other European countries, care and
treatment of people with intellectual disability and psychiatric
problems became separated from psychiatric care for those
without intellectual disability in the 1950s and 1960s. Institutions
for patients with intellectual disability and general mental health
were separately commissioned by different funding streams in the
Netherlands, and since then, each institution’s knowledge of the
other has diminished over the years. As we know from two previous
studies,1–3 the prevalence of mild intellectual disability (MID)
or borderline intellectual functioning (BIF) is much higher in
(general) mental healthcare, as may be expected from the prevalence
estimations in the general population. This finding was remarkable,
given the background of the development of separate intellectual
disability services alongside standard psychiatric care in the
Netherlands. In the study, more than 40% of psychiatric in-patients
and out-patients screened were suspected to have MID/BIF, using
the Screener for Intelligence and Learning Disability (SCIL).4 The
study validated the SCIL against the Wechsler Adult Intelligence
Scale (WAIS)5 in participating patients with severe mental illness
(SMI). In the Netherlands, the SCIL is a widely accepted screener
used in psychiatric and forensic settings.
The population prevalence of MID is estimated to be 0.7 ± 1.3%
in Western countries.6,7 On the basis of the normal distribution of
intelligence in the general population, 2.1% would have an IQ in
the 50–70 range (MID) and 13.6% would have an IQ in the 71–84
range (BIF). Possibly, persons with MID/BIF have a higher likeli-
hood of requiring psychiatric care, and relatively often this need
for care may be long term and intense.
Improper diagnosis may lead to developing SMI
For a number of decades, there is an awareness in psychiatry that
patients with schizophrenia, substance and alcohol use disorders
and bipolar disorder are at risk of developing cognitive decline,8,9
and so in the assessment of intellectual impairment, cognitive
decline needs to be ruled out. To our knowledge, there are no
studies examining the prevalence of MID/BIF in general psychiatry,
correcting for possible impaired cognitive functioning, either at
birth or acquired in childhood or after 18 years of age.
Aim of this study
This study investigated intellectual disability and its possible associ-
ation with cognitive decline in different general mental healthcare
settings, each providing an increasingly longer-term treatment.
When MID/BIF is not properly identified by clinicians, this may
lead to missed, improper or false diagnosis and treatment,10 fol-
lowed by a longer history of psychiatric care, lower quality of life,
worse functioning and possible higher care costs.11 As such, these
patients may develop SMI.12 Patients with SMI may be defined as
having one or more psychiatric disorders (psychosis, severe depres-
sion, personality disorders and bipolar disorder, perhaps in combin-
ation with several other disorders), together with social functioning*Deceased.
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problems for at least 2 years.13 Clinical treatment of schizophrenia,
mood disorders and personality disorders is different when a patient
has an intellectual disability.14 Treatment for addiction is also differ-
ent in a number of aspects if an intellectual disability has to be taken
into account.15,16 A clear diagnosis at an early stage is therefore
important in preventing long-term care dependency.
The aim of this study was to investigate the prevalence of a pos-
sible MID/BIF and possible cognitive decline in different mental
healthcare settings in the Netherlands. In addition, we investigated
the association betweenMID/BIF and patient characteristics such as
age, gender, diagnosis and global functioning. Our hypothesis was
that lower intellectual functioning is associated with a higher preva-
lence of SMI, a more chronic disease course, higher care intensity
and worse functioning.
Method
The study was conducted and reported in accordance with the
Strengthening the Reporting of Observational Studies in
Epidemiology guidelines for reporting observational studies.17
Screening of potential intellectual disabilities was done from May
2014 to January 2019. All patients at participating wards or care
centres were asked to join the study. We used consecutive sampling,
thus asking all new patients to participate; all participants provided
informed consent. This allowed for non-response analysis, adding
to the clinical validity of the findings.18
Setting
We collected a consecutive sample of patients treated with four differ-
ent types of care in a mental healthcare trust in the east of the
Netherlands, covering a catchment area of 630 000 inhabitants. This
Trust covers all specialised mental healthcare in the catchment area,
with an annual total of about 18 000 out-patient referrals and approxi-
mately 2500 in-patient referrals, of which approximately 200 patients
reside in long-stay wards. It is a standardmental health trust, of which
the Netherlands has 24. The four types of care included were:
(a) Out-patient clinics, where patients were referred to after having
been treated with insufficient effect by a general practitioner,
community nurse or psychologist.
(b) Flexible assertive community treatment (FACT) teams, specia-
lising in daily (out-patient) support and treatment for patients
with SMI. In the Netherlands, FACT teams are multidisciplin-
ary out-patient teams with between eight and ten professionals,
such as a psychiatrist, a psychologist, several nurses and social
workers, in general taking care of 200 patients with SMI.19
(c) General admission wards, admitting both first-onset patients
and patients referred from FACT teams or out-patient
clinics. In addition, patients at these wards were eligible for
the study after at least 6 days on the ward.
(d) Long-stay wards, providing residential care for patients with
SMI. The teams at these wards have a similar setup to the
FACT teams. Patients all have a long history of receiving pro-
fessional support and treatment, primarily in the FACT teams.
Patients were excluded if they had an inadequate grasp of the Dutch
language; lack of cooperation; or an inability, in the assessor’s
opinion, to concentrate for at least 20 min to engage in the test as
outlined in the instruction.20
Measures
MID/BIF screening with the SCIL
Weused the SCIL to detect patients suspected forMID or BIF.20 The
SCIL was first used in several published studies in forensic
psychiatry in the Netherlands.21 Translation for use in English is
in preparation. The SCIL comprises 14 questions, including educa-
tion level and small tasks that are intended to provide overall insight
into a patient’s cognitive abilities.20 It was developed specifically to
detect MID/BIF (IQ 50–85) in people in a range of settings, such as
healthcare or social service settings, police stations and shelters for
the homeless. The SCIL adds to other screeners for intellectual dis-
ability, such as the Hayes Ability Screening Index,22 because it
screens for BIF in addition to MID.
The SCILwas validated in an adult sample by comparing the scores
obtainedwith test results from theWAIS III. The reliability of the SCIL,
as expressed in Cronbach’s alpha, was good (0.83 in 318 adults). The
area under the curve value was 0.93, which is excellent. With ≤19 as
a cut-off score, the SCIL accurately classified 82% of people with
MID/BIF. Of the ten people without MID/BIF, nine (89%) were clas-
sified correctly as having no MID/BIF. In accordance with the SCIL
manual, administering the SCIL requires no specific clinical skills.
Recently, the SCIL had been validated in patients with SMI in
FACT teams.3 The Cronbach’s alpha of the SCIL in that sample
was 0.73. The area under the curve value was 0.81 for detecting
MID/BIF and 0.81 for detecting MID, with percentages of correctly
classified individuals of 73% and 79%, respectively. We used two
cut-off scores, 19 and 15. Scoring >19 implied no MID/BIF, and
scoring ≤19 implied suspected MID/BIF. The cut-off point of ≤15
implies an MID.20 In the following descriptions, we use two cut-
off points: 19 for MID or BIF. and 15 for MID only.
Cognitive decline
The SCIL does not distinguish between impaired intellectual func-
tioning caused by cognitive decline and intellectual disability from
birth. To detect a potential cognitive decline after 18 years of age,
we verified patients’ school reports and qualifications in their
medical file. We categorised the school qualifications into four edu-
cation levels, which are related to estimated IQ (WAIS) levels. For
this, we identified the educational attainment of the participants.
We categorised >60 different educational data and certificates into
four categories. By accessing publicly available information, we esti-
mated and verified the content of the educational data and certifi-
cates to WAIS levels. Two team members coded the school
certificates and obtained consensus in a final listing.
Education level 4 corresponds to an estimated IQ outcome on
the WAIS of ≥120, level 3 corresponds to an IQ of 110–120, level
2 corresponds to an IQ of 85–110 and level 1 corresponds to an esti-
mated IQ of 50–85. We compared these levels with SCIL outcomes.
An education level of 2, 3 and 4 with a current SCIL of ≤19, imply-
ing low intellectual functioning after a reasonable educational
attainment, may suggest cognitive decline. Patient characteristics
of patients with a possible cognitive decline were compared with
the patient characteristics of all other patients in the sample. We
performed this comparison to understand whether the patient char-
acteristics associated with intellectual disability were the same as
those associated with cognitive decline.
Demographic and medical information
The following information was extracted from digital medical notes:
age, gender, psychiatric diagnosis (DSM-IV-TR, as assessed by the
psychiatrist) and Global Assessment of Functioning (GAF) score.
In all samples, we included retrospective file information from the
5 years before the SCIL was conducted. A maximum of four
primary DSM diagnoses were included.
Statistical analyses
We calculated the odds ratios when comparing groups, to under-
stand the extent of differences between groups. Where appropriate,
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differences between groups were tested by means of t-tests or χ2-
tests. An alpha of 0.001 was used, because of the large numbers in
the study. Missing values were recorded and reported where they
may be expected to have an effect on the findings.
Ethics
Ethical approval for the study was provided in 2014 by the ethical
board of the University of Twente, Enschede, the Netherlands. All
procedures performed in the current study were in accordance
with the Helsinki Declaration of 1975, as revised in 2008, and
with comparable ethical standards. Data were analysed on the
basis of fully anonymised data that allowed none of the cases to
be traced to an individual.
Results
Patients
We asked 1616 consecutive patients to participate; there was an
available SCIL score in 1213 cases (75.1%). The response did not
vary greatly across settings. At the out-patient clinics the response
rate was 71.3%, followed by the FACT teams with 72.9%. At the
long-stay wards the response rate was 75.8%, whereas at the
general admission wards it was 79.2%. We included 313 patients
from out-patient services, 291 patients from FACT teams, 452
patients from admission wards and 157 patients from long-stay
wards.
Patients in the out-patient services were significantly younger
than in the admission wards, the FACT teams and the long-stay
wards. The long-stay wards had admitted more male patients.
SCIL scores across the settings
Table 1 presents the distribution of SCIL categories across the four
examined settings. The results show that overall, 41.4% of the 1213
included patients had an SCIL score of ≤19 (corresponding to sus-
pectedMID/BIF) and 20.2% had an SCIL score of≤15 (correspond-
ing to likely MID). Of the 313 general out-patients interviewed,
27.2% had an SCIL score of ≤19 (suspected MID/BIF), and 10.2%
had an SCIL score of ≤15 (MID). The 291 patients interviewed at
FACT teams showed a significantly higher prevalence of suspected
intellectual disabilities; 41.2% of the FACT team patients had an
SCIL score of ≤19 and 20.6% had an SCIL score of ≤15. Of the
452 patients interviewed at regular admission wards, 42.5% had
an SCIL score of ≤19 (suspected MID/ BIF) and 19.0% had an
SCIL score of ≤15 (suspected MID). The 157 patients at the long-
stay ward had the highest prevalence of positive SCIL scores;
66.9% had an SCIL score of ≤19 and 42.7% had an SCIL score of
≤15. This increase is also reflected in differences in odds ratios
over the four settings, with the out-patient services at the lower
end (SCIL≤ 19 odds ratio 0.43, SCIL≤ 15 odds ratio 0.37) and
the long-stay wards at the higher end (SCIL≤ 19 odds ratio 3.35,
SCIL≤ 15 odds ratio 3.67).
Diagnosis
When we investigate the differences in diagnosis between those
assessed with the SCIL and those who were not (because they did
not want to or could not participate), we observed no significant dif-
ferences in diagnoses between patients (Table 2).
When we investigate the differences between the various SCIL
groups we did assess, we found that the diagnoses schizophrenia
(odds ratio 2.41, 95% CI 1.81–3.22, P < 0.001), substance use dis-
order (odds ratio 1.84, 95% CI 1.33–2.54, P < 0.005) and intellectual
disability (odds ratio 7.11, 95% CI 4.25–11.88, P < 0.001) were
significantly more prevalent in patients with an SCIL score of
≤19. The same diagnoses were also more prevalent in patients
with an SCIL score of ≤15 (schizophrenia: odds ratio 2.93,
95% CI 2.14–4.01, P < 0.001; substance use disorder: odds ratio
1.70, 95% CI 1.18–2.45, P < 0.05; intellectual disability: odds ratio
5.05, 95% CI 3.32–7.69, P < 0.05). Patients more frequently had a
GAF score <45 if they had an SCIL score of ≤19 (odds ratio 1.68,
95% CI 1.32–2.14, P < 0.001) or an SCIL score of ≤15 (odds ratio
1.97, 95% CI 1.48–2.63, P < 0.001).
Patients with an SCIL score of ≤19 were significantly less fre-
quently diagnosed with anxiety disorder (odds ratio 0.58, 95% CI
0.41–0.82, P < 0.001), depression (odds ratio 0.47, 95% CI 0.36–
0.61, P < 0.001) and personality disorder (odds ratio 0.69, 95% CI
0.54–0.87, P = 0.002). When we compare the above diagnoses in
patients with an SCIL score above or below 15, the outcomes were
nearly the same (odds ratios of 0.63, 0.45 and 0.59, respectively).
When examining the distribution of diagnoses over the four set-
tings, we observed some diagnoses, such as anxiety disorder and
depression, occurring more in out-patient services and admission
wards, whereas others, such as psychotic disorders, schizophrenia,
substance use disorders or a GAF score <45, occurred more in the
FACT teams and long-stay wards (Table 3).
Cognitive decline
Of the 1213 included patients, only 85 (7.1%) had a high education
level (levels 2–4) corresponding with a low SCIL score. In contrast to
this, in patients with an SCIL score of ≤19, 81.6% had a low educa-
tion level (level 1). In patients with an SCIL score of≤15, as many as
84.9% had a low education level (Table 4). We could not clearly
identify the education level of 308 patients (27.3%) without sus-
pected cognitive decline (n = 1128). In the patients with possible
cognitive decline (a high education level and low SCIL), education
levels could not be verified in only four patients (4.7%).
Patients on the long-stay wards were more likely to have a
patient history associated with cognitive decline (odds ratio 2.57,
P < 0.001) than patients from the out-patient services, who were
the least likely group to show evidence of cognitive decline (odds
ratio 0.36, P < 0.001). Figure 1 provides a summary of the propor-
tions of the various SCIL groups (no intellectual disability. suspected
BIF and MID) and the proportions of patients with possible cogni-
tive decline over the wards.
Diagnosis and cognitive decline
In patients with possible cognitive decline, schizophrenia (odds
ratio 1.85, 95% CI 1.03–3.34, P = 0.009) and a GAF score <45
(odds ratio 1.77, 95% CI 1.13–2.78, P = 0.009) were significantly
more often associated with the cognitive decline group (Table 4).
Discussion
Intellectual functioning appears to be a factor that commonly
remains unnoticed,1,2 but is important in the treatment and recov-
ery of psychiatric patients. We found that a strikingly high number
of 41.4% of patients across the four investigated care settings
showed a high probability of MID or BIF. This is significantly
higher than the prevalence expected in the population, but in
keeping with the few existing previous smaller studies.1–3 The
prevalence increased with the intensity level of the mental health-
care provided (lowest in out-patient settings, highest in long-stay
wards). These findings are in line with a recent forensic sample
showing prevalence rates as high as 60%.23 Importantly, in this
study the SCIL findings were validated with concurrent WAIS out-
comes. A recently published, retrospective study by Smits et al24
Intellectual disability prevalence in mental healthcare
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showed that patients in FACT teams with possible BIF can benefit
more from treatment when professionals know about their lower
cognitive level. This same study showed that patients with possible
MID, in contrast, did not benefit from a different approach, and
hardly recovered.
Considering our current findings, although we did not examine
causality, we have to consider the possibility that not recognising
intellectual disability in patients at an early stage may lead to
poorer treatment outcomes. Only 7.1% of all included patients
showed evidence suggesting cognitive decline since adulthood,
which is a lower percentage than expected.5 Somewhat unsurpris-
ingly, most of these patients were on long-stay wards. A total of
72.6% of patients in the long-stay wards turned out to have a low
education level. This suggests that these patients may have already
functioned at a lower intellectual level in their youth. However, it
cannot be ruled out that current psychotropic medication influences
the SCIL outcome. Long-term hospital stay, comorbidmental illness
and limited participation in society, especially for the patients at the
long-stay in-patient wards, may also limit SCIL outcomes.
Nevertheless, the SCIL is an instrument that has no time limit
and deliberately assesses early school skills, making it less dependent
on current social deprivation or medication effects than the WAIS.
After analysis of the existing evidence, we hypothesised that that
lower intellectual functioning is associated with more severe illness, a
poorer prognosis andworse functioning.We know from several intel-
lectual disability studies25,26 in patients withMID in the UK, the USA
and Finland, that schizophrenia, psychotic disorders, aggression and
alcohol and substancemisuse are often reasons for hospital admission
and long-term treatment. Looking at the distribution of diagnoses in
the patients with an SCIL score of ≤19, schizophrenia (odds ratio
2.41), substance use disorder (odds ratio 1.84) and intellectual disabil-
ity (odds ratio 7.11) are significantly more often diagnosed than in
patients with an SCIL score of ≥20. In a review article of psychiatric
disorders in intellectual disability, Morgan et al27 concluded that
schizophrenia was overrepresented among patients with additional
intellectual disability, especially in those in the borderline and MID
range. In addition, Hassiotis et al showed that patients with BIF are
at high risk of developing psychotic symptoms.28 Our findings are
in line with these intellectual disability studies and with more
recent studies about schizophrenia in general psychiatry, which
showed patients with schizophrenia may have a lower education
level because of preadolescent onset of the disease.29 A review
article from Chapman and Wu15 concluded that although the preva-
lence of alcohol and illicit substance use in the intellectual disability
population in the USA is low, the risk of having a substance-related
problem is comparatively high. Prevention and treatment pro-
grammes for these individuals seem to fail. This emphasises the
need to recognise intellectual disability in mental health settings
early, to optimise treatment for substance misuse in this patient
group. Again, our results are in keeping with these findings. We
did not find an increased association of developmental disorders
with MID or BIF, despite our substantial sample size. In line with
underreporting of intellectual disability, underreporting of develop-
mental disorders cannot be ruled out, as was also shown in a recent
study in a long-stay in-patient sample.30
In the UK, the National Intellectual Disability Professional
Senate defined modern specialist community health services for
people with intellectual disability in 2015.31 In the Netherlands,
this patient group is too often not recognised enough, or MID/
BIFmay be cited as a reason to exclude such patients from treatment
programmes. UK studies have shown that, regardless of the method
ormodel used, increasing knowledge, accessibility and collaboration
of both mental health and intellectual disability services improves
functioning of patients with intellectual disability and decreases








n 1616 439 571 399 207
Response 1213 (75.1%) 313 (71.3%) 452 (79.1%) 291 (75.0%) 157 (75.8%)
Mean age (s.d.) 43.1 (11.8) 39.3 (10.8) 43.9 (12.3) 46.5 (10.9) 45.3 (13.3) <0.001
Gender
Male 790 (48.9%) 200 (45.9%) 270 (47.3%) 177 (44.4%) 143 (69.1%) <0.001
Female 826 (51.1%) 239 (54.4%) 301 (52.7%) 222 (55.6%) 64 (30.9%)
Education level
Low 823 (61.7%) 227 (59.4%) 276 (60.5%) 198 (60.4%) 122 (72.6%) 0.020
High 511 (31.6%) 155 (40.6%) 180 (39.5%) 130 (39.6%) 46 (27.4%)
Not assessed 282 (17.4%) 57 (12.9%) 115 (20.1%) 71 (17.8%) 39 (18.9%) <0.001
SCIL outcome
% No SCIL 403 (24.9%) 126 (28.7%) 119 (20.8%) 108 (27.1%) 50 (24.2%) 0.024
Intellectual functioning
% SCIL negative (>19) 711 (58.6%) 228 (72.8%) 260 (57.5%) 171 (58.8%) 52 (33.1%) <0.001
% SCIL positive (≤19) 502 (41.4%) 85 (27.2%) 192 (42.5%) 120 (41.2%) 105 (66.9%)
BIF SCIL positive/negative Odds ratio 0.43 1.07 0.99 3.35
95% CI 0.33–0.57 0.85–1.36 0.76–1.30 2.35–4.78
P-value <0.001 0.551 0.505 <0.001
Mild intellectual disability
% SCIL >15 968 (79.8%) 281 (89.8%) 366 (81.0%) 231 (79.4%) 90 (57.3%) <0.001
% SCIL ≤15 245 (20.2%) 32 (10.2%) 86 (19.0%) 60 (20.6%) 67 (42.7%)
SCIL ≤15/SCIL >15 Odds ratio 0.37 0.89 1.03 3.67
95% CI 0.25–0.55 0.66–1.19 0.75–1.43 2.57–5.24
P-value <0.001 0.240 0.448 <0.001
Cognitive decline
High education level with high SCIL 1128 (93.0%) 303 (96.8%) 420 (92.9%) 270 (92.8%) 135 (86.0%) <0.001
High education level with low SCIL 85 (7.1%) 10 (3.2%) 32 (7.1%) 21 (7.2%) 22 (14%)
SCIL in line with education level/SCIL not in
line with education level
Odds ratio 0.36 1.02 1.04 2.57
95% CI 0.18–0.71 0.65–1.60 0.63–1.74 1.53–4.31
P-value <0.001 0.513 0.481 <0.001
MID, mild intellectual disability; BIF, borderline intellectual functioning; SCIL, Screener for Intelligence and Learning Disabilities; FACT, flexible assertive community treatment team.
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Table 2 Distribution of patient characteristics and diagnosis in patients not assessedwith the SCIL, with SCIL scores above and below 19 (borderline intellectual functioning andmild intellectual disability) andwith SCIL scores
above and below 15 (mild intellectual disability)
n
Below borderline intellectual functioning/mild intellectual disability Mild intellectual disability
% No SCIL % SCIL negative (>19) % SCIL positive (≤19)
SCIL positive/SCIL negative
% SCIL >15 % SCIL ≤15
SCIL ≤15/SCIL >15
Odds ratio 95% CI Odds ratio 95% CI
n 1616 403 711 502 968 245
Response 1213 (75.1%)a 302 (24.9%)b 533 (43.9%)b 378 (31.2%)b
Mean age (s.d.) 44.9 (11.7) 42.1 (11.5) 43.1 (12.4) 42.2 (11.6) 43.9 (12.7)
Gender
Male 790 (48.9%) 193 (47.9%) 336 (47.3%) 261 (52.0%) 0.83 0.66–1.04 462 (47.7%) 135 (55.1%) 0.74 0.56–0.99
Female 826 (51.1%) 210 (52.1%) 375 (52.7%) 241 (48.0%) 506 (52.3%) 110 (44.9%)
Education levelc,d
Low 823 (61.7%) 124 (68.9%) 321 (46.5%) 378 (81.6%) 0.20 0.15–0.26 502 (54.4%) 197 (84.9%) 0.21 0.15–0.31
High 511 (38.3%) 56 (31.1%) 370 (53.5%) 85 (18.4%) 420 (46.5%) 35 (15.1%
Not assessed 282 (17.4%) 122 (30.2%) 20 (2.8%) 39 (7.8%)
Diagnosis
Adjustment disorder 63 (3.9%) 11 (2.7%) 31 (4.4%) 21 (4.2%) 0.96 0.55–1.69 42 (4.3%) 10 (4.1%) 0.94 0.47–1.90
Anxiety disorderc,d 239 (14.8) 124 (17.4%) 124 (17.4%) 55 (11.0%) 0.58 0.41–0.82 153 (15.8%) 26 (10.6%) 0.63 0.41–0.99
Depressionc,d 481 (29.8%) 127 (31.5%) 252 (35.4%) 102 (20.3%) 0.47 0.36–0.61 311 (32.1%) 43 (17.6%) 0.45 0.32–0.64
PTSD diagnosis 301 (18.6%) 77 (19.1%) 125 (17.6%) 99 (19.7%) 1.15 0.86–1.54 180 (18.6%) 44 (18.0%) 0.96 0.67–1.38
Bipolar disorder 163 (10.1%) 31 (7.7%) 73 (10.3%) 59 (11.8%) 1.16 0.81–1.67 10.9 (11.3%) 23 (9.4%) 0.96 0.88–1.05
Psychotic disorders 266 (16.5%) 65 (16.1%) 111 (15.6%) 90 (17.9%) 1.18 0.87–1.60 148 (15.3%) 53 (21.6%) 1.53 1.07–2.17
Schizophreniac,d 341 (21.1%) 101 (25.1%) 99 (13.9%) 141 (28.1%) 2.41 1.81–3.22 153 (15.8%) 87 (35.5%) 2.93 2.14–4.01
Developmental disorder 213 (13.2%) 49 (12.2%) 97 (13.6%) 67 (13.3%) 0.97 0.69–1.36 135 (13.9%) 29 (11.8%) 0.83 0.54–1.28
Substance use disorderc,d 227 (14.0%) 54 (13.4%) 79 (11.1%) 94 (18.7%) 1.84 1.33–2.54 124 (12.8%) 49 (20.0%) 1.70 1.18–2.45
Personality disordera,b 669 (41.4%) 186 (46.2%) 309 (43.5%) 174 (34.7%) 0.69 0.54–0.87 409 (42.3%) 74 (30.2%) 0.59 0.44–0.79
Intellectual disabilityc,d 136 (8.4%) 35 (8.7%) 19 (2.7%) 82 (16.3%) 7.11 4.25–11.88 49 (5.1%) 52 (21.2%) 5.05 3.32–7.69
GAF score <45c,d,e 564 (36.3%) 147 (37.5%) 208 (30.9%) 209 (42.9%) 1.68 1.32–2.14 300 (32.6%) 117 (48.8%) 1.97 1.48–2.63
Assessed 1616 (100%) 403 (100%) 711 (100%) 502 (100%) 968 (100%) 245 (100%)
SCIL, Screener for Intelligence and Learning Disabilities; PTSD, post-traumatic stress disorder; GAF, Global Assessment of Functioning.
a. Column percentage (per cent response in patients over the whole group).
b. Row percentage (distribution of the various SCIL groups over the 1213 respondents).
c. Significant difference between SCIL positive and SCIL negative (borderline intellectual functioning), P < 0.001 one-sided χ2-test.
d. Significant difference between SCIL below 15 and above 15 (mild intellectual disability), P < 0.001 one-sided χ2-test.
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in-patients referrals.26 Healthcare providers should develop effect-
ive training packages regarding the treatment of intellectual disabil-
ity in standard mental healthcare settings.
In summary, this study shows that there is a strong association
between suspected MID/BIF, diagnoses such schizophrenia and
addiction, worse overall functioning and a long history of psychi-
atric care. The finding that high or low SCIL outcomes are asso-
ciated with high or low educational attainment level suggests a
pre-existing impaired intellectual level. The patient journey
usually starts in out-patient services. Professionals’ knowledge of
the diagnostic process and treatments, adapted to the cognitive
and intellectual needs of patients with BIF and MID, are important
for the effectiveness of such treatments. In the Netherlands, the spe-
cific needs of patients with intellectual disabilities are often omitted
from the training of professionals. We know that psychiatric
patients with intellectual disability can significantly benefit from
treatment. The literature confirms that patients with BIF/MID
living in long-term residential facilities30 who are re-diagnosed in
a specialised centre for intellectual disability and psychiatry, not
only obtained other, but also multiple diagnoses. The interference
of the intellectual disability and its interconnection with a lower
level of emotional maturity demands a thorough assessment. If
not recognised, patients with possibly unidentified BIF and MID
may end up being classed as having an SMI, and costs may rise
rapidly because of failed treatment approaches. BIF/MID can thus
become a significant risk factor for developing chronicity.
Therefore, it is important to be aware of the intellectual functioning
of each patient. We recommend screening patients for intellectual
disability as far as practically possible, as part of any assessment at
the start of treatment.
Knowledge about the diagnostic process and effective treatment
for patients with BIF and MID are important. We know that treat-
ments are effective for psychiatric patients with intellectual disabil-
ity. Patients who do not follow the expected path of recovery may
benefit from input from intellectual disability specialists, for a diag-
nostic re-assessment and specialised treatment plan.
A limitation of this study is that cognitive decline remains an
estimation within all the patients assessed with the SCIL, and
based on education level as documented in the medical file. Both
SCIL scores and the categorisation of educational certificates into
Table 3 Distribution of diagnosis over settings
Diagnosis Out-patient clinics Admission wards FACT teams Long-stay wards P-value
Adjustment disorder 63 (3.9%) 18 (4.1%) 30 (5.3%) 10 (2.5%) 5 (2.4%) 0.106
Anxiety disorder 239 (14.8%) 87 (19.8%) 88 (15.4%) 47 (11.8%) 17 (8.2%) <0.001
Depression 481 (29.8%) 161 (36.7%) 231 (40.5%) 81 (20.3%) 8 (3.9%) <0.001
PTSD diagnosis 301 (18.6%) 68 (15.5%) 141 (24.7%) 83 (20.8%) 9 (4.3%) <0.001
Bipolar disorder 163 (10.1%) 20 (4.6%) 77 (13.5%) 54 (13.5%) 12 (5.8%) <0.001
Psychotic disorder 266 (16.5%) 13 (3.0%) 131 (22.9%) 70 (17.5%) 52 (25.1%) <0.001
Schizophrenia 341 (21.1%) 3 (0.7%) 91 (15.9%) 115 (28.8%) 132 (63.8%) <0.001
Developmental disorder 213 (13.2%) 58 (13.2%) 65 (11.4%) 62 (15.5%) 28 (13.5%) 0.314
Substance use disorder 227 (14.0%) 20 (4.6%) 92 (16.1%) 54 (13.5%) 61 (29.5%) <0.001
Personality disorder 669 (41.4%) 188 (42.8%) 232 (40.6%) 187 (46.9%) 62 (30.0%) <0.001
Intellectual disability 136 (8.4%) 5 (1.1%) 47 (8.2%) 45 (11.3%) 39 (18.8%) <0.001
Low GAF score 564 (36.3%) 56 (14.4%) 257 (45.6%) 123 (31.2%) 128 (62.1%) <0.001
FACT, flexible assertive community treatment team; PTSD, post-traumatic stress disorder; GAF, Global Assessment of Functioning.
Table 4 Diagnostic characteristics of patients with a high education level but low SCIL score (likely cognitive decline rather than intellectual disability
from birth)
Low education level and low SCIL score or
high education level and high SCIL score
High education level and
low SCIL score
SCIL in line with
education level/SCIL not
in line with education
level
P-valueOdds ratio 95% CI
n 1128 85
% 92.9% 7.1%
Education level not verifiable 308 (27.3%) 4 (4.7%)
Diagnosis
Adjustment disorder 49 (4.3%) 3 (3.5%) 0.80 0.25–2.64 0.498
Anxiety disorder 168 (14.9%) 11 (12.9%) 0.85 0.44–1.63 0.382
Depression 335 (29.7%) 19 (22.4%) 0.68 0.40–1.15 0.093
PTSD diagnosis 208 (18.4%) 16 (18.8%) 1.02 0.58–1.80 0.512
Bipolar disorder 117 (10.4%) 15 (17.6%) 1.85 1.03–3.34 0.038
Psychotic disorders 188 (16.7%) 13 (15.3%) 0.90 0.49–1.66 0.441
Schizophrenia 214 (19.0%) 26 (30.6%) 1.88 1.16–3.06 0.009
Developmental disorder 156 (13.8%) 8 (9.4%) 0.64 0.31–1.37 0.162
Substance use disorder 153 (13.6%) 20 (23.5%) 1.96 1.15–3.33 0.012
Personality disorder 454 (40.2%) 29 (34.1%) 0.77 0.48–1.22 0.159
Intellectual disability 95 (8.4%) 6 (7.1%) 0.83 0.35–1.94 0.426
GAF score <45 377 (34.9%) 40 (48.8%) 1.77 1.13–2.78 0.009
Out-patient wards 303 (26.9%) 10 (11.8%) 0.36 0.18–0.71 0.001
Admission wards 420 (37.2%) 32 (37.6%) 1.02 0.65–1.60 0.513
FACT teams 270 (23.9%) 21 (24.7%) 1.04 0.62–1.74 0.481
Long-stay in-patient wards 135 (12.0%) 22 (25.9%) 2.57 1.53–4.31 0.001
SCIL, Screener for Intelligence and Learning Disabilities; PTSD, post-traumatic stress disorder; GAF, Global Assessment of Functioning; FACT, flexible assertive community treatment team.
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WAIS levels are estimates. Furthermore, intellectual ability may not
necessarily be linked to academic achievements.32 In 27% of those
patients with an SCIL outcome in line with the SCIL score, and
5% of those with a high education and low SCIL score, the education
level could not be verified from the medical file. Also, patients with
preadolescent schizophrenia with very early cognitive decline were
not detected in this study.29 Other factors, such as psychotropic
medication, long-term hospital stay, comorbid psychiatric illness
and limited participation in society may also have negatively influ-
enced the outcomes of the SCIL.
The strengths of this study are the number of included patients
and the high recruitment rate of 75%. To our knowledge, the preva-
lence of intellectual impairment and cognitive decline of psychiatric
patients over different settings has not been studied before. Another
strength is the use of the SCIL, as this instrument assesses BIF in
addition to MID, adding to current knowledge that primarily
focusses on the association of intellectual disability with psychiatric
disorders.
In conclusion, this study shows that 40% of patients in a general
mental health trust in the Netherlands are suspected for an MID or
borderline intellectual disability across different settings, which is
far more than expected. Only 7% of those were assessed as having
acquired cognitive decline since adolescence. The prevalence of sus-
pected intellectual disability increased in settings providing increas-
ingly more intensive and longer-term treatment. When intellectual
disability is not properly identified by clinicians, it may lead to
improper or false diagnosis and treatment, poorer functioning
and perhaps higher care costs. We therefore recommend that clin-
icians screen for intellectual functioning at the start of treatment
and work together in a multidisciplinary way, to prevent long-
term care dependency.
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